Stocks · News reference
cbdMD Q3 2026 Earnings Call: Complete Transcript
On Thursday, cbdMD (AMEX:YCBD) discussed third-quarter financial results during its earnings call. The full transcript is provided below. This content is powered by Benzinga APIs. For comprehensive financial data and
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
8-K filing — cbdMD, Inc. (YCBD)
Filed: 2026-09-02 AccNo: 0001437749-26-029455 Size: 596 KB Item 1.01: Entry into a Material Definitive Agreement Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
This Workday Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Monday
WALL analysts changed outlook on top names. See upgrades, downgrades & initiations on analyst ratings page. Workday downgraded, price target cut.
Maxim Group Downgrades cbdMD to Hold
Maxim Group analyst Anthony Vendetti downgrades cbdMD (AMEX:YCBD) from Buy to Hold.